Tamoxifen resistance-related ceRNA network for breast cancer

Overview of attention for article published in Frontiers in Cell and Developmental Biology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,394 followers.

We've detected a paper from Frontiers in Cell and Developmental Biology that cites a retracted paper post-retraction. Citing paper: https://t.co/Ypa0UPPVLJ Retracted paper: https://t.co/arX6PEEeme

06 Jan 2023

Reply Repost Favourite

Tamoxifen resistance-related ceRNA network for breast cancer. https://t.co/pdgGCEdWEP

13 Dec 2022

Reply Repost Favourite

New Research: Tamoxifen resistance-related ceRNA network for breast cancer: Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its… https://t.co/GnRFY

25 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.